Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Stock analysts at Ventum Cap Mkts lowered their FY2024 earnings per share estimates for shares of Cresco Labs in a research note issued to investors on Monday, November 11th. Ventum Cap Mkts analyst A. Semple now forecasts that the company will post earnings of ($0.17) per share for the year, down from their prior forecast of ($0.16). Ventum Cap Mkts has a “Strong-Buy” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Ventum Cap Mkts also issued estimates for Cresco Labs’ FY2025 earnings at ($0.08) EPS.
A number of other research analysts also recently issued reports on the company. Roth Capital upgraded Cresco Labs to a “strong-buy” rating in a report on Sunday, November 10th. Needham & Company LLC restated a “hold” rating on shares of Cresco Labs in a report on Monday, August 12th. Finally, Cormark cut Cresco Labs from a “moderate buy” rating to a “hold” rating in a research report on Monday, November 11th. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $2.50.
Cresco Labs Stock Down 0.7 %
Shares of OTCMKTS:CRLBF opened at $1.39 on Thursday. Cresco Labs has a 1 year low of $1.02 and a 1 year high of $2.65. The company has a market cap of $678.51 million, a PE ratio of -7.00 and a beta of 1.88. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.97 and a quick ratio of 1.30. The stock’s 50-day moving average is $1.57 and its 200 day moving average is $1.70.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Featured Articles
- Five stocks we like better than Cresco Labs
- Consumer Discretionary Stocks Explained
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Stock Splits, Do They Really Impact Investors?
- Top-Performing Non-Leveraged ETFs This Year
- What Is WallStreetBets and What Stocks Are They Targeting?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.